ArticleEFSA journal. European Food Safety Authority2026
Potential entry pathways for 25 vector-borne disease agents.
Article in EFSA journal. European Food Safety Authority, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Rift Valley Fever at Europe's Risk Frontier: Climate, Vectors, and One Health Preparedness.Veterinary sciences · 2026Review
- Vector-borne diseases-knowledge maps.EFSA journal. European Food Safety Authority · 2026Article
- Potential entry pathways for 25 vector-borne disease agents.EFSA journal. European Food Safety Authority · 2026Article
- Knowledge mapping of risk mitigation measures against vector-borne diseases.EFSA journal. European Food Safety Authority · 2026Article
- Identification and mapping of potential and highly likely vectors for selected vector-borne diseases in the EU and neighbouring countries.EFSA journal. European Food Safety Authority · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This Scientific Report identifies the potential entry pathways for 25 selected vector-borne diseases (VBDs) into currently free EU Member States. The diseases comprise 12 listed under the Animal Health Law (AHL) and 13 non-listed diseases, selected using predefined eligibility criteria. The report represents a preparatory step supporting subsequent EU-level risk assessments of disease introduction, spread and impact, with emphasis on pathway identification rather than risk estimation. Evidence was collected through structured narrative literature reviews, complemented by expert judgement. Entry pathways were classified as vector-related or non-vectorial. A conservative, inclusion-based approach was applied, whereby only pathways considered with high certainty to be epidemiologically irrelevant were excluded. For tick-borne pathogens, the only potential vector-related entry pathway is the movement of ticks attached to livestock, wildlife or pets. For sandfly-borne pathogens, entry may occur through local dispersal and gradual expansion of established vector populations. For
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.